Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Robotic Partial Nephrectomy Outcomes Evaluated

BJU Int; ePub 2017 Dec 12; Xia, Pulido, et al

People with renal cell carcinoma (RCC) who undergo robot-assisted partial nephrectomy (RAPN) at higher volume hospitals appear to experience better perioperative outcomes and have lower rates of positive surgical margin, according to a study involving nearly 19,000 individuals. Participants with RCC underwent RAPN between 2010 and 2013. Investigators grouped cases into very low-, low-, medium-, high-, and very high-volume categories, and evaluated certain outcomes. Among the results:

  • There were no significant differences in 30- and 90-day mortality rates across groups.
  • Patients at very high-volume centers were 53% less likely to experience open conversion than those at very low-volume centers.
  • Patients at high-, medium-, and low-volume centers were also less likely to experience conversion (43%, 40%, and 12%, respectively)
  • Those at very high-, high-, medium-, and low-volume centers were less likely to experience prolonged length of stay (55%, 38%, 25%, and 7%, respectively).
  • They were also less likely to experience positive surgical margin (66%, 41%, 24%, and 24%, respectively).

Citation:

Xia L, Pulido J, Chelluri R, et al. Hospital volume and outcomes of robot-assisted partial nephrectomy. [Published online ahead of print December 12, 2017]. BJU Int. doi:10.1111/bju.14099

This Week's Must Reads

Overall survival factor in metastatic ccRCC, Thiery-Vuillemin A et al. Clinical Genitourinary Cancer 2018; 16: e297-e305

High perirenal fat thickness predicts poor progression-free survival in patients with localized ccRCC, Huang H et al. Urologic Oncology: Seminars and Original Investigations 2018; 36: 157.e1-157.e6

AXL linked to worse outcome of metastatic RCCs treated with sunitinib, Zucca L E et al. Urologic Oncology: Seminars and Original Investigations 2018: 36; 11.e13-11.e21

Pathologic predictors in lymph node dissection of metastatic RCC, Chipollini J et al. Clinical Genitourinary Cancer 2018; 16: Pages e443-450.

Plated-lymphocyte ratio is correlated with poor prognosis in RCC, Wang Z et al. Clinica Chimica Acta; 2018; 480: 166-72.

Must Reads in Renal Cell Carcinoma

Overall survival factor in metastatic ccRCC, Thiery-Vuillemin A et al. Clinical Genitourinary Cancer 2018; 16: e297-e305

High perirenal fat thickness predicts poor progression-free survival in patients with localized ccRCC, Huang H et al. Urologic Oncology: Seminars and Original Investigations 2018; 36: 157.e1-157.e6

AXL linked to worse outcome of metastatic RCCs treated with sunitinib, Zucca L E et al. Urologic Oncology: Seminars and Original Investigations 2018: 36; 11.e13-11.e21

Pathologic predictors in lymph node dissection of metastatic RCC, Chipollini J et al. Clinical Genitourinary Cancer 2018; 16: Pages e443-450.

Plated-lymphocyte ratio is correlated with poor prognosis in RCC, Wang Z et al. Clinica Chimica Acta; 2018; 480: 166-72.